Amarin Corp plc (ADR) (NASDAQ:AMRN)

CAPS Rating: 4 out of 5

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.


Player Avatar eyehelper (< 20) Submitted: 1/27/2013 8:31:35 PM : Outperform Start Price: $7.99 AMRN Score: -88.82

Too much supply in market already. There is nothing unique about purified fish oil except marketing.

Member Avatar jspendmd1 (< 20) Submitted: 2/4/2013 12:02:31 PM
Recs: 0

It sounds like you have a negative opinion of the product. Why the up thumb?

Featured Broker Partners